Научно-исследовательский институт - Краевая Клиническая больница №1 имени профессора С.В. Очаповского - крупнейшее учреждение здравоохранения юга России, выполняющее более 50000 операций в год. Больница является одним из крупнейших кардиохирургических центров России.

During the past decade, Regional Clinical Hospital #1 conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Regional Clinical Hospital #1" are "Carcinoma, Non-Small-Cell Lung" (1 trials), "Hip Fracture" (1 trials), "Infection" (1 trials), "Rheumatoid Arthritis" (1 trials) and "Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Regional Clinical Hospital #1" in a lesser frequency.

Most popular intervention types in "Regional Clinical Hospital #1" are "Drug" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Alectnib" (1 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials), "DMARDs (disease-modifying antirheumatic drugs)" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Regional Clinical Hospital #1" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Regional Clinical Hospital #1". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Regional Clinical Hospital #1, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Regional Clinical Hospital #1, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".